No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Fusion Proteins, bcr-abl / genetics*
-
Humans
-
Imatinib Mesylate
-
Janus Kinase 2 / genetics*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Male
-
Mutation*
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Reverse Transcriptase Polymerase Chain Reaction
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl
-
Janus Kinase 2